Elevance Health, Inc.

Equities

ELV

US0367521038

Managed Healthcare

Real-time Estimate Cboe BZX 08:10:41 17/07/2024 pm IST 5-day change 1st Jan Change
520.1 USD -5.98% Intraday chart for Elevance Health, Inc. -3.13% +9.82%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday MT
Transcript : Elevance Health, Inc., Q2 2024 Earnings Call, Jul 17, 2024
Stock Futures Decline as Traders Await More Earnings; Asia, Europe Churn MT
Elevance Health's Q2 Adjusted Earnings, Revenue Increase MT
Elevance beats profit estimates on lower-than-expected medical costs RE
Earnings Flash (ELV) ELEVANCE HEALTH Posts Q2 Revenue $43.22B, vs. Street Est of $42.90B MT
Elevance Health, Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 25, 2024 CI
Earnings Flash (ELV) ELEVANCE HEALTH Posts Q2 EPS $10.12, vs. Street Est of $10.01 MT
Elevance Health beats quarterly profit estimates RE
Elevance Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Truist Securities Adjusts Price Target on Elevance Health to $620 From $600, Maintains Buy Rating MT
50 billion dollars - What US insurers pocketed for fictitious illnesses Our Logo
Elevance Health, Inc.(NYSE:ELV) dropped from Russell 1000 Dynamic Index CI
Investors need more time to assess Fed comments Our Logo
CMS to rework quality ratings for Medicare Advantage plans RE
ANALYST RECOMMENDATIONS : Adobe, Bank of America, Boeing, Nvidia, Wise... Our Logo
Transcript : Elevance Health, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 01:20 PM
Sector Update: Health Care Stocks Rise Late Afternoon MT
Sector Update: Health Care MT
Elevance Health's Near-Term Earnings Objectives 'Easily Achievable,' BofA Says MT
Elevance Health Can 'Easily' Achieve Near-Term EPS Growth Outlook, Says BofA Securities MT
BofA Securities Raises Price Target on Elevance Health to $646 From $621, Maintains Buy Rating MT
BofA Securities Adjusts Price Target on Elevance Health to $646 From $621, Maintains Buy Rating MT
Transcript : Elevance Health, Inc. Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-31-2024 09:00 AM
JPMorgan Adjusts Price Target on Elevance Health to $631 From $628 MT
Chart Elevance Health, Inc.
More charts
Elevance Health, Inc. is the American leading of health insurance. The group provides a broad range of medical and specialty products and services (life and disability insurance, medication, dental, vision insurance system and behavioral care insurance system, long-term health care insurance, medical expenses management, etc.). Elevance Health, Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an independent association providing health insurance system. At the end of 2023, the group had nearly 47 million medical members.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
553.1 USD
Average target price
610 USD
Spread / Average Target
+10.28%
Consensus
  1. Stock Market
  2. Equities
  3. ELV Stock
  4. News Elevance Health, Inc.
  5. Earnings Flash (ELV) ELEVANCE HEALTH Posts Q2 Revenue $43.22B, vs. Street Est of $42.90B